266 related articles for article (PubMed ID: 24030970)
1. Energy metabolism characterization of a novel cancer stem cell-like line 3AB-OS.
Palorini R; Votta G; Balestrieri C; Monestiroli A; Olivieri S; Vento R; Chiaradonna F
J Cell Biochem; 2014 Feb; 115(2):368-79. PubMed ID: 24030970
[TBL] [Abstract][Full Text] [Related]
2. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
Di Fiore R; Marcatti M; Drago-Ferrante R; D'Anneo A; Giuliano M; Carlisi D; De Blasio A; Querques F; Pastore L; Tesoriere G; Vento R
Bone; 2014 Mar; 60():198-212. PubMed ID: 24373920
[TBL] [Abstract][Full Text] [Related]
3. Modeling human osteosarcoma in mice through 3AB-OS cancer stem cell xenografts.
Di Fiore R; Guercio A; Puleio R; Di Marco P; Drago-Ferrante R; D'Anneo A; De Blasio A; Carlisi D; Di Bella S; Pentimalli F; Forte IM; Giordano A; Tesoriere G; Vento R
J Cell Biochem; 2012 Nov; 113(11):3380-92. PubMed ID: 22688921
[TBL] [Abstract][Full Text] [Related]
4. Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.
Di Fiore R; Fanale D; Drago-Ferrante R; Chiaradonna F; Giuliano M; De Blasio A; Amodeo V; Corsini LR; Bazan V; Tesoriere G; Vento R; Russo A
J Cell Physiol; 2013 Jun; 228(6):1189-201. PubMed ID: 23129384
[TBL] [Abstract][Full Text] [Related]
5. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
[TBL] [Abstract][Full Text] [Related]
6. Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment.
Di Fiore R; Santulli A; Ferrante RD; Giuliano M; De Blasio A; Messina C; Pirozzi G; Tirino V; Tesoriere G; Vento R
J Cell Physiol; 2009 May; 219(2):301-13. PubMed ID: 19160414
[TBL] [Abstract][Full Text] [Related]
7. Unveiling the protein signature of the human osteosarcoma 3AB-OS cancer stem cell line.
Imperlini E; Corbo C
Biochem Biophys Res Commun; 2023 Oct; 676():36-41. PubMed ID: 37481941
[TBL] [Abstract][Full Text] [Related]
8. Surface proteomic analysis of differentiated versus stem-like osteosarcoma human cells.
Gemei M; Corbo C; D'Alessio F; Di Noto R; Vento R; Del Vecchio L
Proteomics; 2013 Nov; 13(22):3293-7. PubMed ID: 24106197
[TBL] [Abstract][Full Text] [Related]
9.
Jovičić MŠ; Pušić M; Antunović M; Ledinski M; Librenjak L; Kolundžić R; Ribičić T; Trkulja V; Urlić I
Acta Pharm; 2022 Dec; 72(4):599-613. PubMed ID: 36651364
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor binding protein 5 suppresses tumor growth and metastasis of human osteosarcoma.
Su Y; Wagner ER; Luo Q; Huang J; Chen L; He BC; Zuo GW; Shi Q; Zhang BQ; Zhu G; Bi Y; Luo J; Luo X; Kim SH; Shen J; Rastegar F; Huang E; Gao Y; Gao JL; Yang K; Wietholt C; Li M; Qin J; Haydon RC; He TC; Luu HH
Oncogene; 2011 Sep; 30(37):3907-17. PubMed ID: 21460855
[TBL] [Abstract][Full Text] [Related]
11. Cancer cells recovering from damage exhibit mitochondrial restructuring and increased aerobic glycolysis.
Akakura S; Ostrakhovitch E; Sanokawa-Akakura R; Tabibzadeh S
Biochem Biophys Res Commun; 2014 Jun; 448(4):461-6. PubMed ID: 24802411
[TBL] [Abstract][Full Text] [Related]
12. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma.
Shen YA; Wang CY; Hsieh YT; Chen YJ; Wei YH
Cell Cycle; 2015; 14(1):86-98. PubMed ID: 25483072
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological or genetic inhibition of LDHA reverses tumor progression of pediatric osteosarcoma.
Gao S; Tu DN; Li H; Jiang JX; Cao X; You JB; Zhou XQ
Biomed Pharmacother; 2016 Jul; 81():388-393. PubMed ID: 27261617
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial bioenergetic background confers a survival advantage to HepG2 cells in response to chemotherapy.
Loiseau D; Morvan D; Chevrollier A; Demidem A; Douay O; Reynier P; Stepien G
Mol Carcinog; 2009 Aug; 48(8):733-41. PubMed ID: 19347860
[TBL] [Abstract][Full Text] [Related]
15. The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors.
Dani N; Olivero M; Mareschi K; van Duist MM; Miretti S; Cuvertino S; Patané S; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF
J Bone Miner Res; 2012 Jun; 27(6):1322-34. PubMed ID: 22367914
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor alpha increases aerobic glycolysis and reduces oxidative metabolism in prostate epithelial cells.
Vaughan RA; Garcia-Smith R; Trujillo KA; Bisoffi M
Prostate; 2013 Oct; 73(14):1538-46. PubMed ID: 23818177
[TBL] [Abstract][Full Text] [Related]
17. Induction of iPS cells and of cancer stem cells: the stem cell or reprogramming hypothesis of cancer?
Trosko JE
Anat Rec (Hoboken); 2014 Jan; 297(1):161-73. PubMed ID: 24293264
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor β1 signal is crucial for dedifferentiation of cancer cells to cancer stem cells in osteosarcoma.
Zhang H; Wu H; Zheng J; Yu P; Xu L; Jiang P; Gao J; Wang H; Zhang Y
Stem Cells; 2013 Mar; 31(3):433-46. PubMed ID: 23225703
[TBL] [Abstract][Full Text] [Related]
19. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
[TBL] [Abstract][Full Text] [Related]
20. Oxidative metabolism in cancer growth.
Ristow M
Curr Opin Clin Nutr Metab Care; 2006 Jul; 9(4):339-45. PubMed ID: 16778561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
